Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Ocugen (OCGN) has a market cap of $0.22 billion USD. According to our data, Ocugen is ranked No.7017 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $0.22 B |
-6.05%
|
| Dec 31, 2024 | $0.23 B |
40.00%
|
| Dec 29, 2023 | $0.17 B |
-55.77%
|
| Dec 30, 2022 | $0.38 B |
-71.43%
|
| Dec 31, 2021 | $1.33 B |
148.63%
|
| Dec 31, 2020 | $0.53 B |
251.92%
|
| Dec 31, 2019 | $0.15 B |
-90.15%
|
| Dec 31, 2018 | $1.54 B |
-95.71%
|
| Dec 29, 2017 | $35.83 B |
22.75%
|
| Dec 30, 2016 | $29.19 B |
-52.29%
|
| Dec 31, 2015 | $61.18 B |
-68.18%
|
| Dec 31, 2014 | $192.27 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
 BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
 Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
 Inovio Pharmaceuticals
INO
|
$81.23 M |
0.000 M
|
USA
|
 Vaxart
VXRT
|
$0.19 B |
-0.000 M
|
USA
|
 Dynavax Technologies
DVAX
|
$1.63 B |
-0.000 M
|
USA
|
 Curevac
CVAC
|
$0.89 B |
0.000 M
|
Germany
|
 AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
 Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
 Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
 Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
 GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
 Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
| Market Cap | = | OCGN Stock Price | * | OCGN Shares Outstanding |
| = | $0.76 | * | 0.29 B | |
| = | $0.22 B |